stockrowGenmab A/S Sponsored ADR
GMAB Healthcare Biotechnology
Genmab A/S Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 19.2% from fiscal 2024.
- Revenue
- +24.9%
- EPS
- −9.26%
- Free cash flow
- −7.69%
Quarter to June 2026, against a year earlier
Follow GMAB
Alert me
Genmab A/S Sponsored ADR (GMAB) Operating cash flow
Genmab A/S Sponsored ADR's operating cash flow for fiscal 2025 was $1.2B, up 5.33% from $1.1B in fiscal 2024. Over the twelve months to 30 June 2026 it was $891.0M. Over the past ten years it has ranged from $46.5M (fiscal 2016) to $1.2B (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 4 consecutive fiscal years. Genmab A/S Sponsored ADR ranks 10th of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.2B | 5.33% |
| FY2024 | $1.1B | 5.08% |
| FY2023 | $1.1B | 93.45% |
| FY2022 | $553.9M | 56.27% |
| FY2021 | $354.5M | (64.03%) |
| FY2020 | $985.5M | 395.82% |
| FY2019 | $198.8M | 23.66% |
| FY2018 | $160.7M | (37.18%) |
| FY2017 | $255.9M | 449.98% |
| FY2016 | $46.5M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $51.0M | 1,600.00% |
| Mar 2026 | $3.0M | (99.00%) |
| Dec 2025 | $301.0M | (43.84%) |
| Sep 2025 | $536.0M | 764.52% |
| 26 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| RPRX Royalty Pharma PLC compare | $3.0B |
| ONC BeOne Medicines Ltd. - Sponsored ADR compare | $1.6B |
| ALNY Alnylam Pharmaceuticals, Inc. compare | $955.9M |
| GMAB Genmab A/S Sponsored ADR | $891.0M |
| INCY Incyte Corporation compare | $745.0M |
| BNTX BioNTech SE Sponsored ADR compare | −$277.2M |
| INSM Insmed, Inc. compare | −$595.6M |
| ROIV Roivant Sciences Ltd. compare | −$816.5M |
| RVMD Revolution Medicines, Inc. compare | −$1.4B |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on GMAB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement